Hi,
I've gone to the last several meetings but I can't go to this one, so someone will have to ask about Teradyne besides me, this time.
Last year they said that the products they made in the quarter before the meeting (for Intel, I think, and I'd have to check my notes to be sure of the quarter) had lower margins than some of the earlier quarters. If you (or anyone who goes) can, try to find out if that explains the lower than expected results in the last quarter - lower margin products rather than the accounting change. I know that everyone says it's the accounting change, but I don't see it that way. If you can't get the answer there, I'll call them.
Also, try to pin them down on what earnings would have been without delaying the recognition of the Summit handler revenue. It looked to me like it has been in the last two quarters, so it isn't a special deal for this last quarter. But again, I could be wrong.
Finally, and maybe most importantly, how are orders going for the current quarter - increasing, decreasing, staying flat?
Thanks to whoever gets the answers.
Ross |
